http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S562913-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2de3beee83d9c19278da409b72c777a8
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-553
filingDate 1979-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55cebb05ab5490c6c537cc62b0b0c8d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4fa224b6fc0269d55fde893b96e3837
publicationDate 1981-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S562913-A
titleOfInvention Antitumor agent
abstract PURPOSE: An antitumor agent without increasing the toxicity and side effects, comprising a 5-fluorouracil and 2,4-dihydroxypyridine as active constituents. n CONSTITUTION: An antitumor agent comprising (A) at least one 5-fluorouracil selected from the group consisting of compounds of formula I (R 1 and R 2 are H, halogen, alkyl, alkynyl, alkenyl, aryl, aliphatic acyl groups, etc.) and of formula II (R 3 and R 4 are H, alkyl, cycloalkyl, aryl, aralkyl, tetrahydrofurfuryl groups or sugar residues, R 3 and R 4 are not H at the same time), e.g. N'-ethoxymethyl-5- fluorouracil, and (B) 2,4-dihydroxypyridine at a molar ratio of (A) to (B) of 1:0.01W50, in various forms for oral administration, e.g. a tablet or capsule, or for parenteral administration, e.g. an injection or suppository. n COPYRIGHT: (C)1981,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9221345-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S62258367-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S60199881-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5525603-A
priorityDate 1979-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419764094
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504969
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413028087
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23259151
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID232678549
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54696004
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3385

Total number of triples: 27.